Results 11 to 20 of about 9,389 (136)

Pattern and Visual Prognostic Factors of Behcet’s Uveitis in Northwest Iran

open access: yesJournal of Ophthalmic & Vision Research, 2022
Purpose: To investigate the pattern of ocular involvement in Behcet's disease (BD) with predictors of patients' final state of vision. Methods: This historical cohort encompassed the clinical records of 200 patients diagnosed according to the ...
Leila Alizadeh Ghavidel   +5 more
doaj   +1 more source

Could Mean Platelet Volume Be Used as A Marker for Oral Aphthae and Activity of Behçet’s Disease?

open access: yesİstanbul Medical Journal, 2016
Objective: Behçet’s disease is a common inflammatory disease in our country. We aimed to determine whether mean platelet volume can be used as a marker for oral aphthae and the activity of Behçet’s disease.Methods: Between 04/01/2010 and 30/07/2010, 78 ...
Okan Dikker   +5 more
doaj   +1 more source

Low Level Laser Therapy to Reduce Recurrent Oral Ulcers in Behçet’s Disease

open access: yesCase Reports in Dentistry, 2016
Behçet’s disease (BD) is a chronic, relapsing multisystemic vascular condition. Behçet’s disease was described by Hulusi Behçet in 1937. This rare multisystem relapsing-remitting inflammatory disease is poorly understood but is thought to be an ...
D. B. Gandhi Babu   +4 more
doaj   +1 more source

The acquisition of trisomy 8 associated with Behçet's-like disease in myelodysplastic syndrome

open access: yesLeukemia Research Reports, 2020
A relationship has been reported between myelodysplastic syndrome (MDS) and autoimmune disease. Behçet's disease is a multisystem inflammatory disorder with mucocutaneous, articular, gastrointestinal, neurological, and vascular manifestations.
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
doaj   +1 more source

Budd-Chiari syndrome in a 25-year-old woman with Behçet's disease: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2011
Introduction The risk that patients with Behçet's disease will develop thrombotic complications has been previously described. Although it is distributed worldwide, Behçet's disease is rare in the Americas and Europe.
Évora Paulo RB   +4 more
doaj   +1 more source

Behçet's Disease (Adamantiades-Behçet's Disease)

open access: yesClinical and Developmental Immunology, 2011
Adamantiades-Behçet's disease (ABD) is characterized by starting with oral aphthous ulceration and developing of the systemic involvements. The pathogenesis of ABD is closely correlated with the genetic factors and the triggering factors which acquire ...
Fumio Kaneko   +7 more
doaj   +1 more source

Behcet’s Disease; do natural killer cells play a significant role?

open access: yesFrontiers in Immunology, 2015
Behçet's Disease is a complex inflammatory disease, of unknown aetiology. While disease pathogenesis remains unclear, a strong relationship between Behçet’s Disease and HLA-B*51 has been established over the last 30 years.
Harry ePetrushkin   +4 more
doaj   +1 more source

Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis

open access: yesArthritis Care &Research, EarlyView.
Objective This study aims to identify factors associated with patient global assessment (PtGA) and physician global assessment (PhGA) and discordance between them in systemic sclerosis (SSc). Methods Data from adults with early SSc (<5 years) from the Collaborative National Quality and Efficacy Registry were included.
Ellen Romich   +35 more
wiley   +1 more source

Spontaneous resolution of unilateral Behcet's associated neuroretinitis

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: Behcet's disease is an immune-mediated condition which can commonly have ocular involvement. We present a case of Behcet's associated neuroretinitis, which is a rare ocular manifestation of Behcet's disease. Observations: The patient experienced
George Skopis, Sneha Padidam, Brian Do
doaj   +1 more source

An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway

open access: yesAdvanced Science, EarlyView.
A cationic poly(disulfide)‐drug nanoplatform (LA/DexP) was developed to treat experimental autoimmune uveitis (EAU). With potent blood‐retinal barrier penetrability, LA/DexP releases DSP in response to high ROS and scavenges cfDNA to inhibit the cGAS‐STING signaling pathway.
Yuelan Wu   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy